Breast Cancer Drug Mechanisms Flashcards
(31 cards)
Raloxifene
SERM
Binds to ERs, where it has agonist/antagonist actions depending on the tissue
Estrogenic on bone
Anti-estrogenic on breast
Tamoxifen
SERM
Binds to ERs, where it has agonist/antagonist actions depending on the tissue
Estrogenic on bone, uterus
Anti-estrogenic on breast
Ademaciclib (Verzenio)
CDK 4/6 inhibitor -> prevents phosphorylation/inactivation of Rb protein -> prevents DNA transcription by E2F needed for DNA replication
Methotrexate
Antimetabolite
Inhibits dihydrofolate reductase -> dec. active folate -> dec. thymidine -> dec. DNA synthesis
Paclitaxel Albumin-stabilized Nanoparticle Formulation (Abraxane)
Microtubule inhibitor
Albumin carries paclitaxel into tumor interstitium via albumin-activated gp60 pathway
Ado-Trastuzumab (Kadcyla, TDM1)
Trastuzumab binds to HER2 receptor -> flags cells for immune destruction, decreases intercellular HER2-directed growth pathways
Emtansine is a microtubule inhibitor
Everolimus (Afinitor)
mTOR inhibitor -> dec. cell proliferation
Hypoxia-inducible factor inhibitor -> dec. VEGF
Anastrozole (Arimidex)
Aromatase inhibitor
Capecitabine (Xeloda)
Antimetabolite
Prodrug converted to 5-FU -> thymidylate synthetase inhibitor -> dec. thymidine -> dec. DNA synthesis
Cyclophosphamide (Cytoxan)
Alkylating agent
Creates crosslinks between DNA -> dec. DNA synthesis
Docetaxel (Taxotere)
Microtubule inhibitor
Hyperstabilizes microtubules -> prevents microtubule disassembly -> dec. cell division
Doxorubicin (Adriamycin)
DNA intercalater -> prevents DNA/RNA polymerase from attaching to base pairs
Topoisomerase II inihbitor
Epirubicin (Ellence)
DNA intercalater -> prevents DNA/RNA polymerase from attaching to base pairs
Topoisomerase II inihbitor
Eribulin (Halaven)
Microtubule inhibitor
Exemestane (Aromasin)
Steroidal aromastase inhibitor
Letrozole (Femara)
Non-steroidal aromatase inhibitor
Gemcitabine (Gemzar)
Thymidylate synthetase inhibitor -> dec. thymidine -> dec. DNA synthesis
Goserelin (Zoladex)
Synthetic analogue of LHRH -> Inhibition of pituitary gonadotropin secretion -> dec. LH -> ovarian suppression of E
Trastuzumab (Herceptin)
Binds to Her2 -> flags cells for immune destruction, decreases intercellular HER2-directed growth pathways
Palbociclib (Ibrance)
CDK 4/6 inhibitor -> prevents phosphorylation/inactivation of Rb protein -> prevents DNA transcription by E2F needed for DNA replication
Ixabepilone (Ixempra)
Microtuble inhibitor
Ribociclib (Kisqali)
CDK 4/6 inhibitor -> prevents phosphorylation/inactivation of Rb protein -> prevents DNA transcription by E2F needed for DNA replication
Lapatinib (Tykerb)
4-anilinoquinazoline kinase inhibitor of EGFR and EGFR type 2 -> inhibits ErbB-driven growth
Neratinib (Nerlynx)
Irreversibly binds to EGFR, Her2, and Her4 -> prevents autophosphorylation of tyrosine on receptors -> dec. oncogenic signaling